The VESL Wall, Issue #2 is now available! This month we explore the cardiovascular and renal protective effects of SGLT2i in patients with and without diabetes, and the unique challenges of cardiovascular health in the developing world.
The VESL Wall Issue #2 was sent to all VESL members by email on Monday, March 29, and can be accessed online here. View Dr. Robert Hegele’s 10-minute video summary here. To view all issues of the VESL Wall, go to veslcommunity.org/the-vesl-wall
Introducing the “VESL Wall”, a monthly selection of articles for the VESL community with highlights of clinical impact and Canadian perspective
Welcome to the inaugural edition of the VESL Wall. Each month we will feature a few articles recently posted in the VESL community and highlight their clinical impact and Canadian perspective. The first issue of the VESL Wall, including a video summary by Dr. Liam Brunham, was sent to all VESL members by email on … Continue reading Introducing the “VESL Wall”, a monthly selection of articles for the VESL community with highlights of clinical impact and Canadian perspective
We’re pleased to announce the launch of a new initiative called VESL (Virtual Engagement Social Learning), an online learning community for Canadian healthcare professionals with an interest in atherosclerotic cardiovascular disease. VESL will foster open scientific discussions through online forums, webinars and micro-learning objects, to sustain ongoing connection anchored in scientific discovery and expert insight. … Continue reading Launch of the VESL Community